Scholars Central

EditorialPublished Feb 2013

Nanotechnology for Circulating Tumor Biomarker Analysis

Authors: Giuseppe Toffoli, Matteo Castronovo, Flavio Rizzolio

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nanotechnology for Circulating Tumor Biomarker Analysis Circulating biomarkers are essential for cancer diagnosis and progression monitoring. Nowadays, it is commonly accepted and widely highlighted the need to discover tumour markers to enable early diagnosis, prognosis as well as giving insight into pathogenesis and identifying potentially new treatments. In early stage disease, the application of adjuvant chemo- or radio- therapy after surgery depends on the risk of early tumor recurrence and in advanced stage diseases, the choice between aggressive and mild therapies depends on the stratification of patient risk. Once again, prognostic information relative to cancer patients is expected to allow the definition of effective and personalized treatment strategies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomarkers in Drug Development.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomarkers in Drug Development
  • SubjectPathology & Lab Medicine
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Giuseppe Toffoli”
  • BylineArticles whose byline prints “Matteo Castronovo”
  • BylineArticles whose byline prints “Flavio Rizzolio”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels